Get 50% OFF This Summer!

Advertisement
logo

Procter & Gamble Hygiene and Health Care

PGHH
Mid Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

Procter & Gamble Hygiene and Health Care Share price and Fundamental Analysis

View All Details
View All Details
Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. The Company's products are sold through retail operations including mass merchandisers, grocery stores, membership club stores, drug stores, department stores and high frequency stores. The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, apart from third party manufacturing locations spread across India..
Company Incorporation1964
ChairmanChittranjan Dua
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
46,336
PE Ratio
64.72
Industry P/E
62.14
PEG Ratio
-12.25
ROE
75.7%
ROCE
108.26%
ROA
34.14%
Total Debt (Cr)
2.57
Debt to Equity
0
Dividend Yield
1.79%
EPS
220.55
Book Value & P/B
291.35 x 49.0
Face Value
10
Outstanding Shares(Cr)
3.25
Current Ratio
1.41
EV to Sales
10.58

Included In

+More

Stock Returns

1 Week+1.82%
1 Month+1.82%
6 Months-9.01%
1 Year-8.75%
3 Years+8.4%
5 Years+43.68%

CAGR

1 Year CAGR

Revenue Growth

+7.35%

Net Profit Growth

-0.46%

Operating Profit Growth

+12.46%

Dividend Growth

+37.84%

Stock Returns CAGR

-8.75%
no_data

No Stocks

Smart Score

2.9
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 70.64%

FIIs : 1.33%

DIIs : 15.51%

Public : 12.52%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
DII Shareholding Increased by 0.13% to 15.51% in March 2025 Qtr
FII Shareholding Decreased by 0.1% to 1.33% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Procter & Gamble Hygiene and Health Care Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Procter & Gamble Hygiene and Health Care Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. The Company's products are sold through retail operations including mass merchandisers, grocery stores, membership club stores, drug stores, department stores and high frequency stores. The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, apart from third party manufacturing locations spread across India..

The company was incorporated on 20th July 1964 at Mumbai. The Company's saga dates way back to the establishment of Richardson Hindustan Limited (RHL), which obtained an Industrial License to undertake manufacture of Menthol and de mentholised peppermint oil and VICKS range of products such as Vicks VapoRub, Vicks Cough Drops and Vicks Inhaler. The premier product of the company, Vicks Action 500 was launched in the year 1979 and in 1984; an Ayurvedic Research Laboratory was gone to live. In October of the year 1985, RHL became an affiliate of The Procter & Gamble Company, USA. In 1989, Procter & Gamble India (after change in name from RHL) launched Whisper, the breakthrough technology sanitary napkin at first time. In 1991, the company had launched Ariel detergent and also in the same year the Mandideep (Bhopal) Factory started its operations. During the year 1993, P&G had divested the Detergents business to Procter & Gamble Home Products. Goa Honda Factory of the company was started its operations in the year 1996 for manufacture the Vicks Vaporub. After two years, in 1998, Goa Kundiam Factory started its operations for manufacture the Whisper pads.

During the year 1999, the company changed its name from Procter & Gamble India Limited to Procter & Gamble Hygiene and Health Care Limited and also in the identical year, Mediker Shampoo business was divested to Marico Industries. In 2000, the company had introduced Whisper Ultra, Vicks Plus Medicated Lozenges and re launched Vicks Action 500+. To make Indian consumers affordable, the company had reduced its prices on Whisper in the year 2001. P&G had launched New Improved Vicks VapoRub in the year 2002, India's number one Cold Rub that provides multi-symptom relief from the six symptoms of a child's cold and also in the same year launched Vicks Action500+ Night tablets. Vicks Formula 44 Cough Syrup, which was introduced by the company in the year of 2003 to provide safe, effective and long lasting relief for up to eight hours from tough persistent coughs due to colds. P&G had commenced test marketing of economically priced and competitively superior performing, Whisper Choice pads in the southern states of Karnataka, Tamil Nadu, Andhra Pradesh and Kerala during the year 2004. After a year, in 2005, the company had launched Whisper Choice National in Indian market and also acquired Gillette globally. Building the brand equity of Whisper and what's more, has won the Bronze Lion Award at the Cannes International Advertising Festival 2006.

During 2007-08, the company entered into a Public Private Partnership with the National Rural Health Mission, Rajasthan, to provide women in Rajasthan with a better option of sanitary protection and by consequence, a healthier, more productive life.

On 16 March 2016, Procter & Gamble Hygiene and Health Care announced that the Delhi High Court has granted interim injunction suspending Government notification prohibiting the manufacture for sale, sale and distribution for Fixed Dose Combination drugs (Paracetamol + Phenylephrine + Caffeine) till the next hearing. Accordingly, the company will resume manufacture and sale of Vicks Action 500 Extra.

On 1 April 2017, promoter shareholder of Procter & Gamble Hygiene and Health Care, viz., Rosemount LLC transferred 10.88 lakh shares (3.35% of shareholding) held in the company to another promoter group company, Procter & Gamble Overseas India B.V., the Netherlands.

The Board of Directors of Procter & Gamble Hygiene and Health Care at its meeting held on 5 May 2017 declared special interim dividend of Rs 362 per share from accumulated surplus from profits of earlier years and the current year. The dividend demonstrates the company's intent to reward shareholders for strong results in a competitive market environment.

During the Financial Year 2017-18, Company launched Vicks BabyRub, specially developed for babies and gentle on their skin.

Procter & Gamble Hygiene and Health Care Share Price

Procter & Gamble Hygiene and Health Care share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Procter & Gamble Hygiene and Health Care Market Cap

Market capitalization of Procter & Gamble Hygiene and Health Care indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Procter & Gamble Hygiene and Health Care is valued compared to its competitors.

Procter & Gamble Hygiene and Health Care PE Ratio

Procter & Gamble Hygiene and Health Care PE ratio helps investors understand what is the market value of each stock compared to Procter & Gamble Hygiene and Health Care 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Procter & Gamble Hygiene and Health Care PEG Ratio

The PEG ratio of Procter & Gamble Hygiene and Health Care evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Procter & Gamble Hygiene and Health Care ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Procter & Gamble Hygiene and Health Care generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Procter & Gamble Hygiene and Health Care ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Procter & Gamble Hygiene and Health Care in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Procter & Gamble Hygiene and Health Care Total Debt

Total debt of Procter & Gamble Hygiene and Health Care shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Procter & Gamble Hygiene and Health Care Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Procter & Gamble Hygiene and Health Care compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Procter & Gamble Hygiene and Health Care CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Procter & Gamble Hygiene and Health Care over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Procter & Gamble Hygiene and Health Care Technical Analysis

Technical analysis of Procter & Gamble Hygiene and Health Care helps investors get an insight into when they can enter or exit the stock. Key components of Procter & Gamble Hygiene and Health Care Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Procter & Gamble Hygiene and Health Care shares often struggle to rise above due to selling pressure.

Procter & Gamble Hygiene and Health Care Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Procter & Gamble Hygiene and Health Care ’s financial health and profitability.

Procter & Gamble Hygiene and Health Care Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Procter & Gamble Hygiene and Health Care Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Procter & Gamble Hygiene and Health Care Financials

The financials of Procter & Gamble Hygiene and Health Care provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Procter & Gamble Hygiene and Health Care Profit and Loss Statements

The profit and loss statement of Procter & Gamble Hygiene and Health Care highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Procter & Gamble Hygiene and Health Care .

Procter & Gamble Hygiene and Health Care Balance Sheet

The balance sheet presents a snapshot of Procter & Gamble Hygiene and Health Care ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Procter & Gamble Hygiene and Health Care Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App